Compile Data Set for Download or QSAR

Found 183 hits of affinity data for UniProtKB/TrEMBL: Q6UWP7   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Lysocardiolipin acyltransferase 1 (Human)	BDBM532078 (US11208404, Compound 222) Show SMILES CCOc1ccc(CC)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C23H20FN3O4/c1-3-14-7-10-19(29-4-2)16(12-14)21(28)25-18-13-15(8-9-17(18)24)22-26-27-23(31-22)20-6-5-11-30-20/h5-13H,3-4H2,1-2H3,(H,25,28)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	8	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532078 (US11208404, Compound 222) Show SMILES CCOc1ccc(CC)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C23H20FN3O4/c1-3-14-7-10-19(29-4-2)16(12-14)21(28)25-18-13-15(8-9-17(18)24)22-26-27-23(31-22)20-6-5-11-30-20/h5-13H,3-4H2,1-2H3,(H,25,28)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<10	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532078 (US11208404, Compound 222) Show SMILES CCOc1ccc(CC)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C23H20FN3O4/c1-3-14-7-10-19(29-4-2)16(12-14)21(28)25-18-13-15(8-9-17(18)24)22-26-27-23(31-22)20-6-5-11-30-20/h5-13H,3-4H2,1-2H3,(H,25,28)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<10	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532078 (US11208404, Compound 222) Show SMILES CCOc1ccc(CC)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C23H20FN3O4/c1-3-14-7-10-19(29-4-2)16(12-14)21(28)25-18-13-15(8-9-17(18)24)22-26-27-23(31-22)20-6-5-11-30-20/h5-13H,3-4H2,1-2H3,(H,25,28)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<10	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532067 (US11208404, Compound 184) Show SMILES COc1ccc(Cl)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C20H13ClFN3O4/c1-27-16-7-5-12(21)10-13(16)18(26)23-15-9-11(4-6-14(15)22)19-24-25-20(29-19)17-3-2-8-28-17/h2-10H,1H3,(H,23,26)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	18	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532098 (US11208404, Compound 405) Show SMILES COc1ccc(OC(F)(F)F)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H13F4N3O5/c1-30-16-7-5-12(33-21(23,24)25)10-13(16)18(29)26-15-9-11(4-6-14(15)22)19-27-28-20(32-19)17-3-2-8-31-17/h2-10H,1H3,(H,26,29)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	19	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532068 (US11208404, Compound 216) Show SMILES CCOc1ccc(Cl)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H15ClFN3O4/c1-2-28-17-8-6-13(22)11-14(17)19(27)24-16-10-12(5-7-15(16)23)20-25-26-21(30-20)18-4-3-9-29-18/h3-11H,2H2,1H3,(H,24,27)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	19	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532103 (US11208404, Compound 416) Show SMILES COc1ccc(cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1)C(F)(F)F Show InChI InChI=1S/C21H13F4N3O4/c1-30-16-7-5-12(21(23,24)25)10-13(16)18(29)26-15-9-11(4-6-14(15)22)19-27-28-20(32-19)17-3-2-8-31-17/h2-10H,1H3,(H,26,29)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	19	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532086 (US11208404, Compound 317) Show SMILES FC(F)COc1ccc(Cl)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H13ClF3N3O4/c22-12-4-6-16(31-10-18(24)25)13(9-12)19(29)26-15-8-11(3-5-14(15)23)20-27-28-21(32-20)17-2-1-7-30-17/h1-9,18H,10H2,(H,26,29)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	19	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532095 (US11208404, Compound 306) Show SMILES C[F]Oc1ccc(Cl)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C20H13ClF2N3O4/c1-23-30-16-7-5-12(21)10-13(16)18(27)24-15-9-11(4-6-14(15)22)19-25-26-20(29-19)17-3-2-8-28-17/h2-10H,1H3,(H,24,27)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	19	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532093 (US11208404, Compound 304) Show SMILES Fc1ccc(cc1NC(=O)c1cc(Cl)ccc1OC(F)(F)F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C20H10ClF4N3O4/c21-11-4-6-15(32-20(23,24)25)12(9-11)17(29)26-14-8-10(3-5-13(14)22)18-27-28-19(31-18)16-2-1-7-30-16/h1-9H,(H,26,29)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532094 (US11208404, Compound 305) Show SMILES FC(F)Oc1ccc(Cl)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C20H11ClF3N3O4/c21-11-4-6-15(30-20(23)24)12(9-11)17(28)25-14-8-10(3-5-13(14)22)18-26-27-19(31-18)16-2-1-7-29-16/h1-9,20H,(H,25,28)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	21	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532083 (US11208404, Compound 316) Show SMILES Fc1ccc(cc1NC(=O)c1cc(Cl)ccc1OCC(F)(F)F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H12ClF4N3O4/c22-12-4-6-16(32-10-21(24,25)26)13(9-12)18(30)27-15-8-11(3-5-14(15)23)19-28-29-20(33-19)17-2-1-7-31-17/h1-9H,10H2,(H,27,30)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	21	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532091 (US11208404, Compound 281) Show SMILES CCCc1ccc(OC)c(c1)C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C23H20FN3O4/c1-3-5-14-7-10-19(29-2)16(12-14)21(28)25-18-13-15(8-9-17(18)24)22-26-27-23(31-22)20-6-4-11-30-20/h4,6-13H,3,5H2,1-2H3,(H,25,28)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	24	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532071 (US11208404, Compound 183) Show SMILES COc1ccc(Br)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C20H13BrFN3O4/c1-27-16-7-5-12(21)10-13(16)18(26)23-15-9-11(4-6-14(15)22)19-24-25-20(29-19)17-3-2-8-28-17/h2-10H,1H3,(H,23,26)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	24	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532088 (US11208404, Compound 318) Show SMILES C[F]COc1ccc(Cl)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H15ClF2N3O4/c1-24-11-30-17-7-5-13(22)10-14(17)19(28)25-16-9-12(4-6-15(16)23)20-26-27-21(31-20)18-3-2-8-29-18/h2-10H,11H2,1H3,(H,25,28)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	24	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532080 (US11208404, Compound 209) Show SMILES CCCOc1ccc(Cl)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C22H17ClFN3O4/c1-2-9-29-18-8-6-14(23)12-15(18)20(28)25-17-11-13(5-7-16(17)24)21-26-27-22(31-21)19-4-3-10-30-19/h3-8,10-12H,2,9H2,1H3,(H,25,28)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	25	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532073 (US11208404, Compound 215) Show SMILES CCOc1ccccc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H16FN3O4/c1-2-27-17-7-4-3-6-14(17)19(26)23-16-12-13(9-10-15(16)22)20-24-25-21(29-20)18-8-5-11-28-18/h3-12H,2H2,1H3,(H,23,26)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	26	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532085 (US11208404, Compound 323) Show SMILES Cc1ccc(OCC(F)F)c(c1)C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C22H16F3N3O4/c1-12-4-7-17(31-11-19(24)25)14(9-12)20(29)26-16-10-13(5-6-15(16)23)21-27-28-22(32-21)18-3-2-8-30-18/h2-10,19H,11H2,1H3,(H,26,29)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	26	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532076 (US11208404, Compound 315) Show SMILES C[F]COc1ccccc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H16F2N3O4/c1-23-12-29-17-6-3-2-5-14(17)19(27)24-16-11-13(8-9-15(16)22)20-25-26-21(30-20)18-7-4-10-28-18/h2-11H,12H2,1H3,(H,24,27)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	28	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532069 (US11208404, Compound 128) Show SMILES COc1ccccc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C20H14FN3O4/c1-26-16-6-3-2-5-13(16)18(25)22-15-11-12(8-9-14(15)21)19-23-24-20(28-19)17-7-4-10-27-17/h2-11H,1H3,(H,22,25)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	29	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532075 (US11208404, Compound 314) Show SMILES FC(F)COc1ccccc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H14F3N3O4/c22-14-8-7-12(20-26-27-21(31-20)17-6-3-9-29-17)10-15(14)25-19(28)13-4-1-2-5-16(13)30-11-18(23)24/h1-10,18H,11H2,(H,25,28)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	29	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532072 (US11208404, Compound 300) Show SMILES COc1ccc(C)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H16FN3O4/c1-12-5-8-17(27-2)14(10-12)19(26)23-16-11-13(6-7-15(16)22)20-24-25-21(29-20)18-4-3-9-28-18/h3-11H,1-2H3,(H,23,26)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	30	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532077 (US11208404, Compound 221) Show SMILES CCOc1ccc(C)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C22H18FN3O4/c1-3-28-18-9-6-13(2)11-15(18)20(27)24-17-12-14(7-8-16(17)23)21-25-26-22(30-21)19-5-4-10-29-19/h4-12H,3H2,1-2H3,(H,24,27)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	31	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532059 (US11208404, Compound 118) Show SMILES CCOc1ccc(Br)cc1C(=O)Nc1cccc(c1)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H16BrN3O4/c1-2-27-17-9-8-14(22)12-16(17)19(26)23-15-6-3-5-13(11-15)20-24-25-21(29-20)18-7-4-10-28-18/h3-12H,2H2,1H3,(H,23,26)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	31	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532096 (US11208404, Compound 312) Show SMILES C[F]COc1ccc(F)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H15F3N3O4/c1-24-11-30-17-7-5-13(22)10-14(17)19(28)25-16-9-12(4-6-15(16)23)20-26-27-21(31-20)18-3-2-8-29-18/h2-10H,11H2,1H3,(H,25,28)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	33	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532060 (US11208404, Compound 200) Show SMILES CCOc1ccc(I)cc1C(=O)Nc1cccc(c1)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H16IN3O4/c1-2-27-17-9-8-14(22)12-16(17)19(26)23-15-6-3-5-13(11-15)20-24-25-21(29-20)18-7-4-10-28-18/h3-12H,2H2,1H3,(H,23,26)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	33	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532062 (US11208404, Compound 219) Show SMILES CCOc1ccc(CC)cc1C(=O)Nc1cccc(c1)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C23H21N3O4/c1-3-15-10-11-19(28-4-2)18(13-15)21(27)24-17-8-5-7-16(14-17)22-25-26-23(30-22)20-9-6-12-29-20/h5-14H,3-4H2,1-2H3,(H,24,27)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	34	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532087 (US11208404, Compound 320) Show SMILES FC(F)COc1ccc(F)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H13F4N3O4/c22-12-4-6-16(31-10-18(24)25)13(9-12)19(29)26-15-8-11(3-5-14(15)23)20-27-28-21(32-20)17-2-1-7-30-17/h1-9,18H,10H2,(H,26,29)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	34	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532059 (US11208404, Compound 118) Show SMILES CCOc1ccc(Br)cc1C(=O)Nc1cccc(c1)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H16BrN3O4/c1-2-27-17-9-8-14(22)12-16(17)19(26)23-15-6-3-5-13(11-15)20-24-25-21(29-20)18-7-4-10-28-18/h3-12H,2H2,1H3,(H,23,26)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532060 (US11208404, Compound 200) Show SMILES CCOc1ccc(I)cc1C(=O)Nc1cccc(c1)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H16IN3O4/c1-2-27-17-9-8-14(22)12-16(17)19(26)23-15-6-3-5-13(11-15)20-24-25-21(29-20)18-7-4-10-28-18/h3-12H,2H2,1H3,(H,23,26)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532062 (US11208404, Compound 219) Show SMILES CCOc1ccc(CC)cc1C(=O)Nc1cccc(c1)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C23H21N3O4/c1-3-15-10-11-19(28-4-2)18(13-15)21(27)24-17-8-5-7-16(14-17)22-25-26-23(30-22)20-9-6-12-29-20/h5-14H,3-4H2,1-2H3,(H,24,27)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532067 (US11208404, Compound 184) Show SMILES COc1ccc(Cl)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C20H13ClFN3O4/c1-27-16-7-5-12(21)10-13(16)18(26)23-15-9-11(4-6-14(15)22)19-24-25-20(29-19)17-3-2-8-28-17/h2-10H,1H3,(H,23,26)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532068 (US11208404, Compound 216) Show SMILES CCOc1ccc(Cl)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H15ClFN3O4/c1-2-28-17-8-6-13(22)11-14(17)19(27)24-16-10-12(5-7-15(16)23)20-25-26-21(30-20)18-4-3-9-29-18/h3-11H,2H2,1H3,(H,24,27)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532069 (US11208404, Compound 128) Show SMILES COc1ccccc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C20H14FN3O4/c1-26-16-6-3-2-5-13(16)18(25)22-15-11-12(8-9-14(15)21)19-23-24-20(28-19)17-7-4-10-27-17/h2-11H,1H3,(H,22,25)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532071 (US11208404, Compound 183) Show SMILES COc1ccc(Br)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C20H13BrFN3O4/c1-27-16-7-5-12(21)10-13(16)18(26)23-15-9-11(4-6-14(15)22)19-24-25-20(29-19)17-3-2-8-28-17/h2-10H,1H3,(H,23,26)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532072 (US11208404, Compound 300) Show SMILES COc1ccc(C)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H16FN3O4/c1-12-5-8-17(27-2)14(10-12)19(26)23-16-11-13(6-7-15(16)22)20-24-25-21(29-20)18-4-3-9-28-18/h3-11H,1-2H3,(H,23,26)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532073 (US11208404, Compound 215) Show SMILES CCOc1ccccc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H16FN3O4/c1-2-27-17-7-4-3-6-14(17)19(26)23-16-12-13(9-10-15(16)22)20-24-25-21(29-20)18-8-5-11-28-18/h3-12H,2H2,1H3,(H,23,26)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532075 (US11208404, Compound 314) Show SMILES FC(F)COc1ccccc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H14F3N3O4/c22-14-8-7-12(20-26-27-21(31-20)17-6-3-9-29-17)10-15(14)25-19(28)13-4-1-2-5-16(13)30-11-18(23)24/h1-10,18H,11H2,(H,25,28)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532076 (US11208404, Compound 315) Show SMILES C[F]COc1ccccc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H16F2N3O4/c1-23-12-29-17-6-3-2-5-14(17)19(27)24-16-11-13(8-9-15(16)22)20-25-26-21(30-20)18-7-4-10-28-18/h2-11H,12H2,1H3,(H,24,27)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532077 (US11208404, Compound 221) Show SMILES CCOc1ccc(C)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C22H18FN3O4/c1-3-28-18-9-6-13(2)11-15(18)20(27)24-17-12-14(7-8-16(17)23)21-25-26-22(30-21)19-5-4-10-29-19/h4-12H,3H2,1-2H3,(H,24,27)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532080 (US11208404, Compound 209) Show SMILES CCCOc1ccc(Cl)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C22H17ClFN3O4/c1-2-9-29-18-8-6-14(23)12-15(18)20(28)25-17-11-13(5-7-16(17)24)21-26-27-22(31-21)19-4-3-10-30-19/h3-8,10-12H,2,9H2,1H3,(H,25,28)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532083 (US11208404, Compound 316) Show SMILES Fc1ccc(cc1NC(=O)c1cc(Cl)ccc1OCC(F)(F)F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H12ClF4N3O4/c22-12-4-6-16(32-10-21(24,25)26)13(9-12)18(30)27-15-8-11(3-5-14(15)23)19-28-29-20(33-19)17-2-1-7-31-17/h1-9H,10H2,(H,27,30)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532085 (US11208404, Compound 323) Show SMILES Cc1ccc(OCC(F)F)c(c1)C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C22H16F3N3O4/c1-12-4-7-17(31-11-19(24)25)14(9-12)20(29)26-16-10-13(5-6-15(16)23)21-27-28-22(32-21)18-3-2-8-30-18/h2-10,19H,11H2,1H3,(H,26,29)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532086 (US11208404, Compound 317) Show SMILES FC(F)COc1ccc(Cl)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H13ClF3N3O4/c22-12-4-6-16(31-10-18(24)25)13(9-12)19(29)26-15-8-11(3-5-14(15)23)20-27-28-21(32-20)17-2-1-7-30-17/h1-9,18H,10H2,(H,26,29)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532087 (US11208404, Compound 320) Show SMILES FC(F)COc1ccc(F)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H13F4N3O4/c22-12-4-6-16(31-10-18(24)25)13(9-12)19(29)26-15-8-11(3-5-14(15)23)20-27-28-21(32-20)17-2-1-7-30-17/h1-9,18H,10H2,(H,26,29)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532088 (US11208404, Compound 318) Show SMILES C[F]COc1ccc(Cl)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C21H15ClF2N3O4/c1-24-11-30-17-7-5-13(22)10-14(17)19(28)25-16-9-12(4-6-15(16)23)20-26-27-21(31-20)18-3-2-8-29-18/h2-10H,11H2,1H3,(H,25,28)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532091 (US11208404, Compound 281) Show SMILES CCCc1ccc(OC)c(c1)C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C23H20FN3O4/c1-3-5-14-7-10-19(29-2)16(12-14)21(28)25-18-13-15(8-9-17(18)24)22-26-27-23(31-22)20-6-4-11-30-20/h4,6-13H,3,5H2,1-2H3,(H,25,28)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532093 (US11208404, Compound 304) Show SMILES Fc1ccc(cc1NC(=O)c1cc(Cl)ccc1OC(F)(F)F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C20H10ClF4N3O4/c21-11-4-6-15(32-20(23,24)25)12(9-11)17(29)26-14-8-10(3-5-13(14)22)18-27-28-19(31-18)16-2-1-7-30-16/h1-9H,(H,26,29)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair
Lysocardiolipin acyltransferase 1 (Human)	BDBM532094 (US11208404, Compound 305) Show SMILES FC(F)Oc1ccc(Cl)cc1C(=O)Nc1cc(ccc1F)-c1nnc(o1)-c1ccco1 Show InChI InChI=1S/C20H11ClF3N3O4/c21-11-4-6-15(30-20(23)24)12(9-11)17(28)25-14-8-10(3-5-13(14)22)18-26-27-19(31-18)16-2-1-7-29-16/h1-9,20H,(H,25,28)	UniProtKB/SwissProt GoogleScholar	UniChem	US Patent	n/a	n/a	<35	n/a	n/a	n/a	n/a	n/a	n/a
PERENNA PHARMACEUTICALS, INC. US Patent					Assay Description ALCAT1 enzymatic activity was determined by measuring the conversion of monolysocardiolipin (MLCL) to cardiolipin or lysophosphatidylglycerol (LPG) t...				US Patent US11208404 (2021)
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 183 total )  |  Next  |  Last  >>

Jump to: